IP Library Granted Patent US 6,872,183
Granted Patent B2
US 6,872,183 · App. 10/852,648 · Granted Mar 29, 2005

System and method for detecting perforations in a body cavity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,872,183
App. No.
10/852,648
Granted
Mar 29, 2005
Kind
B2
Abstract

A system and method for detecting perforations in a body cavity. In accordance with the method of the invention, a fluid (liquid or gas) is delivered into a body cavity to slightly pressurize the cavity. A pressure sensing system monitors the pressure within the cavity for a predetermined test period. If cavity pressure is not substantially sustained during the test period, the physician is alerted to further assess the cavity for perforations before initiating treatment within the cavity. In a preferred form of the system, a medical treatment system such as an RF ablation system is provided with perforation detection functionality. The system preferably includes a pre-test and post-test lockout system. The lockout system prevents RF power delivery unless, during a predetermined test period, the pressure sensing system determines that no perforation exists, or unless a previously performed perforation detection procedure determined a perforation was present but the lockout system was subsequently overridden by the physician.

Claims (31)

1. A method of ablating a uterus, comprising the steps of:

inserting an ablation device into a uterus;

flowing an inflation medium into the uterus;

monitoring for the presence of a perforation in the uterus using a pressure sensor; and

treating the interior of the uterus using the ablation device.

2. The method of claim 1 , wherein the treating step includes delivering electrical energy to the tissue.

3. The method of claim 2 , wherein the electrical energy is RF energy.

4. The method of claim 1 , wherein the treating step includes delivering thermal energy to the tissue.

5. The method of claim 1 , wherein the flowing step includes:

passing an inflation medium through the ablation device and into the uterus; and

the monitoring step includes monitoring a pressure within the uterus for a predetermined amount of time.

6. The method of claim 1 , further including the step of:

if a perforation is detected in the monitoring step, providing feedback alerting a user to the presence of a preforation in the uterus.

7. The method of claim 1 , further including the step of preventing performance of the treating step until after the monitoring step has been carried out.

8. The method of claim 1 , further including the steps of:

suspending performance of the treating step if a perforation is detected in the monitoring step;

detecting an override signal from a user input device; and

permitting treatment of the uterus using the ablation device following detection of the override signal.

9. A method of detecting a perforation in a uterus, comprising the steps of:

passing an inflation medium into the uterus;

monitoring for the presence of a perforation in the uterus using a pressure sensor;

if no perforation is detected during the monitoring step, permitting ablation of the uterus using an ablation device; and

if a perforation is detected during the monitoring step, preventing ablation of the uterus.

10. The method of claim 9 , further including the step of:

if a perforation is detected during the monitoring step, detecting an override signal from a user input device and permitting treatment of the uterus using the ablation device following detection of the override signal.

11. The method of claim 9 , further including the step of:

if a perforation is detected during the monitoring step, activating a notification signal alerting the user to the presence of a perforation in the uterus.

12. The method of claim 9 , wherein the inflation medium is introduced using a medical device separate from the ablation device.

13. The method of claim 9 , wherein the inflation medium is introduced using the ablation device.

14. The method of claim 9 , wherein the ablation device is an RF ablation device.

15. The method of claim 9 , wherein the ablation device is a thermal ablation device.

Assignments (17)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 036855/0468 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075456/0572 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: TRUCKAI, CSABA; SAMPSON, RUSSEL MAHLON; SQUARCIA, STEPHANIE; RAMIREZ, ALFONZO LAWRENCE; HILARIO, ESTELA
To: NOVACEPT
Reel/Frame 037499/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 15, 2016
From: CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 037499/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: CYTYC SURGICAL PRODUCTS LLC
To: HOLOGIC, INC.
Reel/Frame 037502/0450 →
CHANGE OF NAME Recorded Jan 15, 2016
From: CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: CYTYC SURGICAL PRODUCTS, LLC
Reel/Frame 037543/0093 →
SECURITY AGREEMENT Recorded Oct 14, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LLC; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036855/0468 →
CHANGE OF NAME Recorded Sep 11, 2015
From: CYTEC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: CYTEC SURGICAL PRODUCTS, LLC
Reel/Frame 036589/0796 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 25, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024944/0315 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021311/0118 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020018/0653 →
CHANGE OF NAME Recorded Nov 12, 2004
From: NOVACEPT
To: CYTYC SURGICAL PRODUCTS
Reel/Frame 015991/0624 →